|4Jul 30, 12:27 PM ET

EHRLICH LEO 4

4 · Cellceutix CORP · Filed Jul 30, 2012

Insider Transaction Report

Form 4
Period: 2010-07-27
EHRLICH LEO
DirectorChief Executive Officer10% Owner
Transactions
  • AwardSwap

    Stock Option (right to buy)

    2010-12-29$0.11/sh+6,000,000$660,0006,000,000 total
    Exercise: $0.11From: 2010-12-30Exp: 2020-12-30Common (6,000,000 underlying)
  • Other

    Common

    2010-07-27+1,000,0008,745,002 total
  • AwardSwap

    Common

    2010-12-29$0.11/sh+6,000,000$660,00018,000,000 total
    Exercise: $0.11From: 2012-01-03Exp: 2020-12-30Common (6,000,000 underlying)
  • AwardSwap

    Stock Option

    2010-12-29$0.11/sh+6,000,000$660,00012,000,000 total
    Exercise: $0.11From: 2011-06-30Exp: 2020-12-30Common (6,000,000 underlying)
  • AwardSwap

    Stock Option (right to buy)

    2012-05-19$0.51/sh+2,000,000$1,020,00020,000,000 total
    Exercise: $0.51From: 2012-11-18Exp: 2022-11-18Commom (2,000,000 underlying)
Holdings
  • common

    (indirect: By Spouse)
    2,752,310
  • Common

    (indirect: Daughter)
    749,972
Footnotes (2)
  • [F1]1,000,000 shares was transferred by The Menon Family Trust
  • [F2]Options were issued to Mr. Ehrlich in connection with renegotiating the terms of the outstanding loan balance as of March 31, 2012 of $2,248,037 represented by the Ehrlich Promissory Note C.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT